Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised Double Blind Placebo Controlled Pilot Study of Minocycline and/or Omega-3 Fatty Acids Added to Treatment as Usual for At Risk Mental States

NCT02569307 is registered in ClinicalTrials.gov with Pakistan Institute of Living and Learning as lead sponsor.

NCT NCT02569307
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02569307 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised Double Blind Placebo Controlled Pilot Study of Minocycline and/or Omega-3 Fatty Acids Added to Treatment as Usual for At Risk Mental States
Lead sponsor
Pakistan Institute of Living and Learning
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2015
Completion date
March 31, 2019
Enrollment
326 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

at risk mental state (arms), psychosis